PAX5 and cancer: Our observations also presented significant differences in polymorphic patterns of Pax-5 3′UTRs from clinical samples in comparison to healthy donors (i.e., greater excised 3′UTR regions) where cancer cells possessed overall shorter 3′UTRs.